SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -33.3% | 2,200 | +120.0% | 0.00% | -57.1% |
| Q4 2014 | $15,000 | +36.4% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $11,000 | -26.7% | 1,000 | 0.0% | 0.01% | -58.8% |
| Q2 2014 | $15,000 | -16.7% | 1,000 | 0.0% | 0.02% | +13.3% |
| Q1 2014 | $18,000 | +28.6% | 1,000 | 0.0% | 0.02% | +25.0% |
| Q4 2013 | $14,000 | +40.0% | 1,000 | 0.0% | 0.01% | +20.0% |
| Q3 2013 | $10,000 | +25.0% | 1,000 | 0.0% | 0.01% | -16.7% |
| Q2 2013 | $8,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |